The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab

Marina Papoutsaki,Mark S. Talamonti,Alessandro Giunta,Antonio Costanzo,Manuela Ruzzetti,Miriam Teoli,Sergio Chimenti

The Impact of Methodological Approaches for Presenting Long-Term Clinical Data on Estimates of Efficacy in Psoriasis Illustrated by Three-Year Treatment Data on Infliximab

2010

Marina Papoutsaki
Mark S. Talamonti
Alessandro Giunta
Antonio Costanzo
Manuela Ruzzetti
Miriam Teoli
Sergio Chimenti

Background: Psoriasis affects about 2–3% of the Caucasian population. Biologics such as infliximab, etanercept, adalimumab and ustekinumab are efficacious treatments of plaque-type

Keywords:

Dermatology
Etanercept
Psoriasis
Ustekinumab
Response rate (survey)
Pathology
Infliximab
Population
Adalimumab
Medicine
Adverse effect
long term data
plaque type psoriasis
caucasian population

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations